Study shows improved treatment options in oncology cohorts, indicating effectiveness of genomic profiling features.
This study indicates that the CGP expanded treatment options in both the pilot and expanded cohort, with improvements directly attributable to specific features like tumor-normal matching, liquid biopsy reflex ordering, RNA sequencing, and Just-in-Time clinical trial matching.
No takes yet. Share an insight, caveat, or question.
Porte et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: